CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Siegel Jolie Chief Legal Officer | Grant or award | +27,300 | 52,251 | ||
| 2024-02-14 | Siegel Jolie Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +122,800 | 122,800 | ||
| 2024-02-14 | Schick Kelly Chief People Officer | Grant or award | +27,300 | 52,251 | ||
| 2024-02-14 | Schick Kelly Chief People Officer | Grant or award · Stock Option (Right to Buy) | +122,800 | 122,800 | ||
| 2024-02-14 | Fisher Stewart Chief Scientific Officer | Grant or award | +27,300 | 129,121 | ||
| 2024-02-14 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +122,800 | 122,800 | ||
| 2024-02-14 | Boyle Scott N Chief Business Officer | Grant or award | +27,300 | 52,330 | ||
| 2024-02-14 | Boyle Scott N Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +122,800 | 122,800 | ||
| 2024-02-14 | Adams Kendra Chief Financial Officer | Grant or award | +36,700 | 82,039 | ||
| 2024-02-14 | Adams Kendra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +165,300 | 165,300 | ||
| 2024-02-13 | Siegel Jolie Chief Legal Officer | Shares withheld for taxes | −1,735 | $6.53 | $11K | 24,951 |
| 2024-02-13 | Schick Kelly Chief People Officer | Shares withheld for taxes | −1,735 | $6.53 | $11K | 24,951 |
| 2024-02-13 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −2,255 | $6.53 | $15K | 101,821 |
| 2024-02-13 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −1,735 | $6.53 | $11K | 25,030 |
| 2024-02-13 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,301 | $6.53 | $8K | 45,339 |
| 2024-01-02 | Dubin Glenn Director | Grant or award | +1,687 | $6.52 | $11K | 20,717 |
| 2024-01-02 | Anderson Kenneth Carl Director | Grant or award | +1,725 | $6.52 | $11K | 110,962 |
| 2024-01-02 | GROGAN DONNA ROY Director | Grant or award | +2,108 | $6.52 | $14K | 21,935 |
| 2023-11-16 | Hughes Owen Director | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2023-10-02 | Anderson Kenneth Carl Director | Grant or award | +6,617 | $1.70 | $11K | 109,237 |
Page 10 of 27 · 525 trades